129 related articles for article (PubMed ID: 15140130)
1. The effects of additional carbohydrate in the coiled-coil region of fibrinogen on polymerization and clot structure and properties: characterization of the homozygous and heterozygous forms of fibrinogen Lima (Aalpha Arg141-->Ser with extra glycosylation).
Marchi R; Arocha-Piñango CL; Nagy H; Matsuda M; Weisel JW
J Thromb Haemost; 2004 Jun; 2(6):940-8. PubMed ID: 15140130
[TBL] [Abstract][Full Text] [Related]
2. Biophysical characterization of fibrinogen Caracas I with an Aalpha-chain truncation at Aalpha-466 Ser: identification of the mutation and biophysical characterization of properties of clots from plasma and purified fibrinogen.
Marchi R; Meyer M; de Bosch N; Soria J; Arocha-Piñango CL; Weisel JW
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):285-93. PubMed ID: 15166913
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation (deletion of Aalpha-Asn 80) in an abnormal fibrinogen: fibrinogen Caracas VI. Consequences of disruption of the coiled coil for the polymerization of fibrin: peculiar clot structure and diminished stiffness of the clot.
Marchi RC; Meyer MH; de Bosch NB; Arocha-Piñango CL; Weisel JW
Blood Coagul Fibrinolysis; 2004 Oct; 15(7):559-67. PubMed ID: 15389122
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of fibrinogen Bicêtre II: a gamma 308 Asn-->Lys mutation located near the fibrin D:D interaction sites.
Marchi RC; Carvajal Z; Boyer-Neumann C; Anglés-Cano E; Weisel JW
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):193-201. PubMed ID: 16575257
[TBL] [Abstract][Full Text] [Related]
5. The ultrastructure of fibrinogen Caracas II molecules, fibers, and clots.
Woodhead JL; Nagaswami C; Matsuda M; Arocha-Piñango CL; Weisel JW
J Biol Chem; 1996 Mar; 271(9):4946-53. PubMed ID: 8617768
[TBL] [Abstract][Full Text] [Related]
6. Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness.
Allan P; Uitte de Willige S; Abou-Saleh RH; Connell SD; Ariëns RA
J Thromb Haemost; 2012 Jun; 10(6):1072-80. PubMed ID: 22463367
[TBL] [Abstract][Full Text] [Related]
7. Structure of fibrin network of two abnormal fibrinogens with mutations in the αC domain on the human dermal microvascular endothelial cells 1.
Marchi R; Rojas H; Castillo O; Kanzler D
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):706-11. PubMed ID: 21986467
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen Guarenas, an abnormal fibrinogen with an Aalpha-chain truncation due to a nonsense mutation at Aalpha 467 Glu (GAA)-->stop (TAA).
Marchi R; Carvajal Z; Meyer M; Soria J; Ruiz-Saez A; Arocha-Piñango CL; Weisel JW
Thromb Res; 2006; 118(5):637-50. PubMed ID: 16406498
[TBL] [Abstract][Full Text] [Related]
9. Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers.
Langer BG; Weisel JW; Dinauer PA; Nagaswami C; Bell WR
J Biol Chem; 1988 Oct; 263(29):15056-63. PubMed ID: 3170575
[TBL] [Abstract][Full Text] [Related]
10. Decreased lateral aggregation of a variant recombinant fibrinogen provides insight into the polymerization mechanism.
Mullin JL; Gorkun OV; Lord ST
Biochemistry; 2000 Aug; 39(32):9843-9. PubMed ID: 10933802
[TBL] [Abstract][Full Text] [Related]
11. Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.
Piechocka IK; Kurniawan NA; Grimbergen J; Koopman J; Koenderink GH
J Thromb Haemost; 2017 May; 15(5):938-949. PubMed ID: 28166607
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.
Marchi R; Lundberg U; Grimbergen J; Koopman J; Torres A; de Bosch NB; Haverkate F; Arocha Piñango CL
Thromb Haemost; 2000 Aug; 84(2):263-70. PubMed ID: 10959699
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic dysfibrinogenemia. Fibrinogen "Caracas V" relation between very tight fibrin network and defective clot degradability.
Marchi R; Mirshahi SS; Soria C; Mirshahi M; Zohar M; Collet JP; de Bosch NB; Arocha-Piñango CL; Soria J
Thromb Res; 2000 Jul; 99(2):187-93. PubMed ID: 10946093
[TBL] [Abstract][Full Text] [Related]
14. Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His.
Luo M; Deng D; Xiang L; Cheng P; Liao L; Deng X; Yan J; Lin F
Medicine (Baltimore); 2016 Sep; 95(39):e4864. PubMed ID: 27684817
[TBL] [Abstract][Full Text] [Related]
15. Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.
Hugenholtz GC; Macrae F; Adelmeijer J; Dulfer S; Porte RJ; Lisman T; Ariëns RA
J Thromb Haemost; 2016 May; 14(5):1054-66. PubMed ID: 26833718
[TBL] [Abstract][Full Text] [Related]
16. The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.
Collet JP; Moen JL; Veklich YI; Gorkun OV; Lord ST; Montalescot G; Weisel JW
Blood; 2005 Dec; 106(12):3824-30. PubMed ID: 16091450
[TBL] [Abstract][Full Text] [Related]
17. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots.
Collet JP; Woodhead JL; Soria J; Soria C; Mirshahi M; Caen JP; Weisel JW
Biophys J; 1996 Jan; 70(1):500-10. PubMed ID: 8770228
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of recombinant Bbeta15C and Bbeta15A fibrinogens demonstrates that Bbeta15G residue plays important roles in FPB release and in lateral aggregation of protofibrils.
Hirota-Kawadobora M; Kani S; Terasawa F; Fujihara N; Yamauchi K; Tozuka M; Okumura N
J Thromb Haemost; 2005 May; 3(5):983-90. PubMed ID: 15869595
[TBL] [Abstract][Full Text] [Related]
20. A classification of the fibrin network structures formed from the hereditary dysfibrinogens.
Sugo T; Endo H; Matsuda M; Ohmori T; Madoiwa S; Mimuro J; Sakata Y
J Thromb Haemost; 2006 Aug; 4(8):1738-46. PubMed ID: 16879216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
